NASDAQ:RYTM | Operating Income | RHYTHM PHARMACEUTICALS, INC.

Complete source-backed operating income history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$48.55M
2026-03-31-$52.36M
2025-12-31-$47.06M
2025-09-30-$52.65M
2025-06-30-$45.3M
2025-03-31-$47M
2024-12-31-$41.26M
2024-09-30-$43.89M
2024-06-30-$40.48M
2024-03-31-$139.89M
2023-12-31-$41.27M
2023-09-30-$43.95M
2023-06-30-$46.6M
2023-03-31-$52.53M
2022-12-31-$42.1M
2022-09-30-$39.27M
2022-06-30-$45.1M
2022-03-31-$52.69M
2021-12-31-$50.99M
2021-09-30-$44.24M
2021-06-30-$40.43M
2021-03-31-$34.4M
2020-12-31-$35.07M
2020-09-30-$34.28M
2020-06-30-$31.92M
2020-03-31-$35.3M
2019-12-31-$34.22M
2019-09-30-$37.11M
2019-06-30-$44.15M
2019-03-31-$30.52M
2018-12-31-$27.15M
2018-09-30-$19.24M
2018-06-30-$15.02M
2018-03-31-$17M
2017-12-31-$10.98M
2017-09-30-$8.29M
2017-06-30-$6.75M
2017-03-31-$6.39M
2016-12-31-$8.38M
2016-09-30-$6.4M

Annual Operating Income

DateOperating Income
2025-12-31-$192.02M
2024-12-31-$265.5M
2023-12-31-$184.36M
2022-12-31-$179.16M
2021-12-31-$170.06M
2020-12-31-$136.58M
2019-12-31-$146M
2018-12-31-$78.42M
2017-12-31-$32.41M
2016-12-31-$25.91M
2015-12-31-$10.57M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.